Niosomal drug delivery for transdermal targeting: recent advances

References

• Uchegbu IF, Florence AT. Nonionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci. 1995;58:1–55.
   Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36.
   PubMed Web of Science ®Google Scholar
• Lasic DD. On the thermodynamic stability of liposomes. J Colloid Interface Sci. 1990;140:302–304.
   Web of Science ®Google Scholar
• Gannu PK, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery an overview. Acta Pharmacol Sin. 2011;1:208–219.
   Google Scholar
• Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems – an overview. Adv Colloid Interface Sci. 2012;183:46–54.
   PubMed Web of Science ®Google Scholar
• Obata Y, Takayama K, Maitani Y, Machida Y, Nagai T. Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int J Pharm. 1993;89:191–198.
   Web of Science ®Google Scholar
• Perche F, Torchilin VP. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. J Drug Deliv. 2013;2013:705265.
   PubMedGoogle Scholar
• Pawar SD, Pawar RG, Kodag PP, Waghmare AS. Niosome: an unique drug delivery system. International Journal of Biology, Pharmacy and Allied Sciences. 2012;3:406–416.
   Google Scholar
• Khan A, Sharma PK, Visht S, Malviya R. Niosomes as colloidal drug delivery system: a review. Journal of Chronotherapy and Drug Delivery. 2011;2:15–21.
   Google Scholar
• Florence AT, Baillie AJ. Nonionic surfactant vesicles – alternatives to liposomes. In: Prescott LF, Nimmo WS, editors. Novel Drug Delivery and its Therapeutic Application. New York, NY, USA: John Wiley and Sons Ltd; 1989.
   Google Scholar
• Thakur V, Arora S, Prashar B, Vishal P. Niosomes and liposomes – vesicular approach towards transdermal drug delivery. International Journal of Pharmaceutical and Chemical Sciences. 2012;1:981–993.
   Google Scholar
• Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25:499–512.
   PubMed Web of Science ®Google Scholar
• Handjani-Vila RM, Riber A, Rondot B, Valenberghe G. Aqueous dispersion. Int J Cosmet Sci. 1979;1:303–314.
   PubMed Web of Science ®Google Scholar
• Barel A, Paye M, Maibach HI. Handbook of Cosmetic Science and Technology. New York, NY, USA: Marcel Dekker Inc.; 2001.
   Google Scholar
• Singh S. Niosomes: a role in targeted drug delivery system. Int J Pharm Sci Res. 2013;4:550–557.
   Google Scholar
• Vyas SP, Khar RK.. Novel carrier systems. In: Jain NK, editor. Targeted and Controlled Drug Delivery. New Delhi, India: CBS Publishers and Distributors Pvt Ltd; 2010.
   Google Scholar
• Sahin NO.. Niosomes as nanocarrier systems. In: Mozafari MR, editor. Nanomaterials and Nanosystems for Biomedical Applications. New York, NY, USA: Springer; 2007.
   Google Scholar
• Hofland HE, Bouwstra JA, Verhoef JC, et al. Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants. J Pharm Pharmacol. 1992;44:287–294.
   PubMed Web of Science ®Google Scholar
• Pape WJ, Pfannenbecker U, Hoppe U. Validation of the red blood cell test system as in vitro assay for the rapid screening of irritation potential of surfactants. Mol Toxicol. 1987;1:525–536.
   PubMedGoogle Scholar
• Tavano L, Infante MR, Abo Riya M, et al. Role of aggregate size in the hemolytic and antimicrobial activity of colloidal solutions based on single and gemini surfactants from arginine. Soft Matter. 2013;9:306–319.
   Web of Science ®Google Scholar
• Paolino D, Muzzalupo R, Ricciardi A, Celia C, Picci N, Fresta M. In vitro and in vivo evaluation of bola-surfactant containing niosomes for transdermal delivery. Biomed Microdevices. 2007;9:421–433.
   PubMed Web of Science ®Google Scholar
• Walker RB, Smith EW. The role of percutaneous penetration enhancers. Adv Drug Deliv Rev. 1996;18:295–301.
   Web of Science ®Google Scholar
• Barry BW. Lipid protein partitioning theory of skin penetration enhancement. J Control Release. 1991;15:237–248.
   Web of Science ®Google Scholar
• Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release. 1994;30:1–15.
   Web of Science ®Google Scholar
• Karande P, Mitragotri S, Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009;1788:2362–2373.
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 2002;54:41–55.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R, Tavano L, Cassano R, Trombino S, Ferrarelli T, Picci N. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Biopharm. 2011;79:28–35.
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm. 2006;27:11–19.
   Google Scholar
• Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21:87–100.
   PubMed Web of Science ®Google Scholar
• Mali N, Darandale S, Vavia P. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment. Drug Deliv Transl Res. 2013;3:587–592.
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev. 2004;56:675–711.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 2008;34:203–222.
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, Godin B, Eliaz MJ. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Control Release. 2000;65:403–418.
   PubMed Web of Science ®Google Scholar
• Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS Pharm Sci Tech. 2012;13:1502–1510.
   PubMed Web of Science ®Google Scholar
• Tavano L, Gentile L, Oliviero Rossi C, Muzzalupo R. Novel gel-niosome formulations as multicomponent systems for transdermal drug delivery. Colloids Surf B Biointerfaces. 2013;110:281–288.
   PubMed Web of Science ®Google Scholar
• Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm. 2005;59:485–490.
   PubMed Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH, Patel MR. Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. Asian Journal of Pharmaceutical Sciences. 2010;5:87–95.
   Google Scholar
• El-Menshawe SF, Hussein AK. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Dev Technol. 2013;18:779–786.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Fathalla D, Shakeel F. Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation. Pharm Dev Technol. 2014;9:1–7.
   Google Scholar
• Manosroi A, Jantrawuta P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 2008;360:156–163.
   PubMed Web of Science ®Google Scholar
• Tavano L, de Cindio B, Picci N, Ioele G, Muzzalupo R. Drug compartmentalization as strategy to improve the physico-chemical properties of diclofenac sodium loaded niosomes for topical applications. Biomed Microdevices. 2014;16:851–858.
   PubMed Web of Science ®Google Scholar
• Das MK, Palei NN. Sorbitan ester niosomes for topical delivery of rofecoxib. Indian J Exp Biol. 2011;49:438–445.
   PubMed Web of Science ®Google Scholar
• Rajnish A, Ajay S. Release studies of ketoprofen niosome. J Chem Pharm Res. 2010;1:79–82.
   Google Scholar
• Ammar HO, Ghora M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm. 2011;405:142–152.
   PubMed Web of Science ®Google Scholar
• Zidan AS, Mokhtar M. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics. J Pharm Sci. 2011;100:2212–2221.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77:43–55.
   PubMed Web of Science ®Google Scholar
• Keservani RK, Sharma AK, Ramteke S. Novel vesicular approach for topical delivery of baclofen via niosomes. Lat Am J Pharm. 2010;29:1364–1370.
   Web of Science ®Google Scholar
• Zhang Y, Zhang K, Wu Z, et al. Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake. Int J Pharm. 2015;478:138–146.
   PubMed Web of Science ®Google Scholar
• Tavano L, Alfano P, Muzzalupo R, de Cindio B. Niosomes vs microemulsions: new carriers for topical delivery of capsaicin. Colloids Surf B Biointerfaces. 2011;87:333–339.
   PubMed Web of Science ®Google Scholar
• Tavano L, Muzzalupo R, Picci N, de Cindio B. Co-encapsulation of lipophilic antioxidants into niosomal carriers: Percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces. 2014;114:114–149.
   Web of Science ®Google Scholar
• Manosroi A, Chankhampan C, Manosroi W, Manosroi J. Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment. Eur J Pharm Sci. 2013;48:474–483.
   PubMed Web of Science ®Google Scholar
• Shaker DS, Nasr M, Mostafa M. Bioavailability and hypocholesterolemic effect of proniosomal simvastatin for transdermal delivery. International Journal of Pharmacy and Pharmaceutical Sciences. 2013;5:344–351.
   Google Scholar
• Zidan AS, Hosny KM, Ahmed OA, Fahmy UA. Assessment of simvastatin niosomes for pediatric transdermal drug delivery. Drug Deliv. 2014;11:1–14.
   Google Scholar
• El Maghraby GM, Ahmed AA, Osman MA. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. Saudi Pharm J. 2015;23:67–74.
   PubMed Web of Science ®Google Scholar
• Yasam VR, Jakki SL, Natarajan J, et al. Novel vesicular transdermal delivery of nifedipine – preparation, characterization and in vitro/in-vivo evaluation. Drug Deliv. 2014;9:1–12.
   Google Scholar
• Muzzalupo R, Tavano L, Lai F, Picci N. Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium salt. Colloids Surf B Biointerfaces. 2014;123:207–212.
   PubMed Web of Science ®Google Scholar
• Kong M, Park H, Feng C, Hou L, Cheng X, Chen X. Construction of hyaluronic acid niosome as functional transdermal nanocarrier for tumor therapy. Carbohydr Polym. 2013;94:634–641.
   PubMed Web of Science ®Google Scholar
• Kassem MA, Esmat S, Bendas ER, El-Komy MH. Efficacy of topical griseofulvin in treatment of tinea corporis. Mycoses. 2006;49:232–235.
   PubMed Web of Science ®Google Scholar
• Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel – an adjuvant in the treatment of psoriasis. International Journal of Pharmaceutical Sciences Review and Research. 2011;7:1–7.
   Google Scholar
• Mazda F, Özer AY, Ercan MT. Preparation and characterisation of urea niosomes – in vitro and in vivo studies. STP Pharm Sci. 1997;7:205–214.
   Google Scholar
• Ribeiro de Souza AL, Kiill CP, Kolenyak dos Santos FK, et al. Nanotechnology-based drug delivery systems for dermatomycosis treatment. Curr Nanosci. 2012;8:512–519.
   Web of Science ®Google Scholar